Am. J. Respir. Crit. Care Med., Volume 158, Number 1, July 1998, 279-288

Developmental Changes in Lung cGMP Phosphodiesterase-5 Activity, Protein, and Message

KIMBERLY A. HANSON, FIONA BURNS, SERGEI D. RYBALKIN, JIM WAGER MILLER, JOSEPH BEAVO, and WILLIAM R. CLARKE

Department of Pediatrics, Department of Anesthesiology, and Department of Pharmacology, University of Washington School of Medicine, Seattle, Washington

During transitional circulation, the pulmonary vascular bed undergoes a rapid and profound reduction in both tone and vascular smooth-muscle (VSM) content. 3',5'-Guanylate cyclic monophosphate (cGMP) is a crucial mediator in the regulation of pulmonary vascular resistance (PVR) and VSM proliferation. Hydrolysis of cGMP is achieved predominately by cGMP-specific phosphodiesterases (PDEs). Among the cGMP-specific PDEs, PDE5 is quantitatively prevalent in lung tissue. We have investigated the levels of pulmonary PDE5 enzymatic activity, protein, and messenger RNA (mRNA) in ovine and mouse lung during perinatal development. We report that within 1 h following birth, PDE5 activity, protein, and mRNA levels decrease in both species, in a manner that correlates with known decreases in PVR in early transition. However, from 4 to 7 d following birth, a secondary increase in PDE5 activity, protein, and mRNA occurs in both ovine and mouse lung, suggesting a complex regulation of PVR and VSM proliferation in late perinatal development. Our data imply that PDE5 may be an important mediator in the regulation of PVR in normal and possibly in pathologic states, and may ultimately provide a basis for PDE5 inhibitors as a treatment for pulmonary hypertension.

This article has been cited by other articles:

				K. N. Farrow, B. S. Groh, P. T. Schumacker, S. Lakshminrusimha, L. Czech, S. F. Gugino, J. A. Russell, and R. H. Steinhorn Hyperoxia Increases Phosphodiesterase 5 Expression and Activity in Ovine Fetal Pulmonary Artery Smooth Muscle Cells Circ. Res., February 1, 2008; 102(2): 226 - 233. [Abstract] [Full Text] [PDF]

				L. G. Chicoine, M. L. Paffett, M. R. Girton, M. J. Metropoulus, M. S. Joshi, J. A. Bauer, L. D. Nelin, T. C. Resta, and B. R. Walker Maturational changes in the regulation of pulmonary vascular tone by nitric oxide in neonatal rats Am J Physiol Lung Cell Mol Physiol, November 1, 2007; 293(5): L1261 - L1270. [Abstract] [Full Text] [PDF]

				R. C. Dukarm, R. H. Steinhorn, J. A. Russell, S. Lakshminrusimha, D. Swartz, and J. J. Cummings Selective type 5 phosphodiesterase inhibition alters pulmonary hemodynamics and lung liquid production in near-term fetal lambs J Appl Physiol, December 1, 2005; 99(6): 2331 - 2336. [Abstract] [Full Text] [PDF]

				P. Deruelle, T. R. Grover, and S. H. Abman Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep Am J Physiol Lung Cell Mol Physiol, November 1, 2005; 289(5): L798 - L806. [Abstract] [Full Text] [PDF]

				B. Larrue, S. Jaillard, M. Lorthioir, X. Roubliova, G. Butrous, T. Rakza, H. Warembourg, and L. Storme Pulmonary vascular effects of sildenafil on the development of chronic pulmonary hypertension in the ovine fetus Am J Physiol Lung Cell Mol Physiol, June 1, 2005; 288(6): L1193 - L1200. [Abstract] [Full Text] [PDF]

				O. Pauvert, S. Bonnet, E. Rousseau, R. Marthan, and J.-P. Savineau Sildenafil alters calcium signaling and vascular tone in pulmonary arteries from chronically hypoxic rats Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L577 - L583. [Abstract] [Full Text] [PDF]

				D. B. Badesch, S. H. Abman, G. S. Ahearn, R. J. Barst, D. C. McCrory, G. Simonneau, and V. V. McLaughlin Medical Therapy For Pulmonary Arterial Hypertension: ACCP Evidence-Based Clinical Practice Guidelines Chest, July 1, 2004; 126(1_suppl): 35S - 62S. [Abstract] [Full Text] [PDF]

				D. Massaro and G. D. Massaro Pre- and Postnatal Lung Development, Maturation, and Plasticity: Invited Review: Pulmonary alveoli: formation, the "call for oxygen," and other regulators Am J Physiol Lung Cell Mol Physiol, March 1, 2002; 282(3): L345 - L358. [Abstract] [Full Text] [PDF]

				A. KLEINSASSER, A. LOECKINGER, C. HOERMANN, F. PUEHRINGER, N. MUTZ, G. BARTSCH, and K. H. LINDNER Sildenafil Modulates Hemodynamics and Pulmonary Gas Exchange Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 339 - 343. [Abstract] [Full Text]

				R. C. DUKARM, J. A. RUSSELL, F. C. MORIN III, B. J. PERRY, and R. H. STEINHORN The cGMP-specific Phosphodiesterase Inhibitor E4021 Dilates the Pulmonary Circulation Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 858 - 865. [Abstract] [Full Text]